AMGEN INC — Director's Dealing 2025

Aug 23, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2025-08-20

Reporting Person: Grygiel Nancy A. (SVP & CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-20	Common Stock	S	1267	$296.985	Disposed	7209	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	103.8077	Indirect

Footnotes

F1: These shares include 80 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F2: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.